Securities Fraud

SOUTH BEND, Ind. — A federal court in Indiana approved a $50 million settlement in a class action securities fraud case brought by investors against medical device company Zimmer Biomet Holdings. The investors claimed the company failed to disclose supply-chain problems that led to a decrease in order fulfillment rates.

%d bloggers like this: